This inventor holds 1 USPTO granted patent. Top assignees: Baolong Pharmaceutical Co., Ltd., Shanghai Baolong Anqing Pharmaceutical Co., Ltd., Shanghai Baolong Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 2 
1 out of 2 Years Active: 2026
Title: Zhizhe Lin: Innovator in Pharmaceutical Formulations
Introduction
Zhizhe Lin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutics, particularly in the development of formulations that enhance drug safety and efficacy. His innovative work has the potential to improve patient outcomes and streamline clinical practices.
Latest Patents
Zhizhe Lin holds a patent for a "Safe and stable nimodipine formulation for injection and method for preparing same." This invention focuses on a lyophilized nimodipine-cyclodextrin powder for injection, which includes sulfobutylether-β-cyclodextrin. This formulation significantly enhances the solubility, safety, and dilution stability of nimodipine, thereby increasing patient compliance and convenience in clinical use. Compared to the commercially available nimodipine injection NIMOTOP, Lin's formulation offers notable advantages in safety and dilution stability.
Career Highlights
Throughout his career, Zhizhe Lin has worked with various companies, including Shanghai Wei Er Biopharmaceutical Technology Co., Ltd. and Shanghai Baolong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Zhizhe Lin has collaborated with notable professionals in his field, including Xin Wu and Youfa Xu. These partnerships have facilitated the advancement of his research and the successful development of his patented formulations.
Conclusion
Zhizhe Lin is a key figure in the pharmaceutical industry, with a focus on creating safer and more effective drug formulations. His innovative contributions are poised to make a lasting impact on patient care and clinical practices.